05
April
2024
|
09:38 AM
America/New_York

Liposomal bupivacaine may augment pain management for spinal fusion

Todd J. Albert, MD, spine surgeon at HSS speaks to Orthopedics Today about a study that finds patients who received liposomal bupivacaine for pain management during lumbar decompression and fusion required fewer opioids post-surgery compared to those who didn't. While length of stay and side effects showed no significant difference, this technique could offer significant benefits amidst the opioid crisis. Further research comparing different pain management strategies is needed to optimize patient outcomes and healthcare costs.

Read the full article at healio.com.